Cargando…
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study
The outcome of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph− ALL) relapsing after pediatric-inspired front-line therapy is ill known. Here 229 relapsing Ph− ALL younger adults (18–63 years) treated within the Group for Research on Adult Acute Lymphoblastic Le...
Autores principales: | Desjonquères, A, Chevallier, P, Thomas, X, Huguet, F, Leguay, T, Bernard, M, Bay, J-O, Tavernier, E, Charbonnier, A, Isnard, F, Hunault, M, Turlure, P, Renaud, M, Bastié, J-N, Himberlin, C, Lepretre, S, Lioure, B, Lhéritier, V, Asnafi, V, Beldjord, K, Lafage-Pochitaloff, M, Béné, M C, Ifrah, N, Dombret, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223147/ https://www.ncbi.nlm.nih.gov/pubmed/27935576 http://dx.doi.org/10.1038/bcj.2016.111 |
Ejemplares similares
-
Monitoring of asparagine depletion and anti-l-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
por: Paillassa, Jérôme, et al.
Publicado: (2018) -
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
por: Cabannes-Hamy, Aurélie, et al.
Publicado: (2022) -
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study
por: Orvain, Corentin, et al.
Publicado: (2023) -
DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia
por: Bond, Jonathan, et al.
Publicado: (2019) -
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
por: Kim, Rathana, et al.
Publicado: (2023)